Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of burns
3.2.1.2 Advancements in treatment
3.2.1.3 Growing awareness and education
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and allergic reactions
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Pricing analysis
3.8 Product differentiation and branding
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antibiotic ointments
5.3 Silver-based ointments
5.4 Iodine-based ointments
5.5 Other product types
Chapter 6 Market Estimates and Forecast, By Depth of Burn, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Minor burns
6.3 Partial thickness burns
6.4 Full thickness burns
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Healthcare facilities
7.3 Homecare settings
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Brick & mortar
8.3 E-commerce
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Ascend Laboratories LLC
10.2 Dr. Morepen
10.3 GlaxoSmithKline
10.4 Green Leaf
10.5 Johnson & Johnson
10.6 Mankind Pharma
10.7 MEDLINE
10.8 Pfizer
10.9 Safetec of America, Inc.
10.10 Smith & Nephew
10.11 Trio Lifescience Private Limited
10.12 WellSpring Pharmaceutical Corporation
